Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 21;11(8):2323.
doi: 10.3390/biomedicines11082323.

Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn't

Catalina Christensen  1 , Martin Rose  1 , Claus Cornett  2 , Morten Allesø  1
Affiliations
Review

Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn't

Catalina Christensen et al. Biomedicines. .

Abstract

The 'entourage effect' term was originally coined in a pre-clinical study observing endogenous bio-inactive metabolites potentiating the activity of a bioactive endocannabinoid. As a hypothetical afterthought, this was proposed to hold general relevance to the usage of products based on Cannabis sativa L. The term was later juxtaposed to polypharmacy pertaining to full-spectrum medicinal Cannabis products exerting an overall higher effect than the single compounds. Since the emergence of the term, a discussion of its pharmacological foundation and relevance has been ongoing. Advocates suggest that the 'entourage effect' is the reason many patients experience an overall better effect from full-spectrum products. Critics state that the term is unfounded and used primarily for marketing purposes in the Cannabis industry. This scoping review aims to segregate the primary research claiming as well as disputing the existence of the 'entourage effect' from a pharmacological perspective. The literature on this topic is in its infancy. Existing pre-clinical and clinical studies are in general based on simplistic methodologies and show contradictory findings, with the clinical data mostly relying on anecdotal and real-world evidence. We propose that the 'entourage effect' is explained by traditional pharmacological terms pertaining to other plant-based medicinal products and polypharmacy in general (e.g., synergistic interactions and bioenhancement).

Keywords: active pharmaceutical ingredient; antagonism; bioenhancer; cannabinoids; drug–drug interaction; entourage effect; medicinal cannabis; polypharmacology; polypharmacy; synergy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Lowe H., Toyang N., Steele B., Bryant J., Ngwa W. The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases. Int. J. Mol. Sci. 2021;22:9472. doi: 10.3390/ijms22179472. - DOI - PMC - PubMed
    1. Ben-Shabat S., Fride E., Sheskin T., Tamiri T., Rhee M.-H., Vogel Z., Bisogno T., De Petrocellis L., Marzo V.D., Mechoulam R. An Entourage Effect: Inactive Endogenous Fatty Acid Glycerol Esters Enhance 2-Arachidonoyl-Glycerol Cannabinoid Activity. Eur. J. Pharmacol. 1998;353:23–31. doi: 10.1016/S0014-2999(98)00392-6. - DOI - PubMed
    1. Mechoulam R., Ben-Shabat S. From Gan-Zi-Gun-Nu to Anandamide and 2-Arachidonoylglycerol: The Ongoing Story of Cannabis. Nat. Prod. Rep. 1999;16:131–143. doi: 10.1039/a703973e. - DOI - PubMed
    1. Russo E.B. Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects. Br. J. Pharmacol. 2011;163:1344–1364. doi: 10.1111/j.1476-5381.2011.01238.x. - DOI - PMC - PubMed
    1. Russo E.B. The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain”, No Gain. Front. Plant Sci. 2019;9:1969. doi: 10.3389/fpls.2018.01969. - DOI - PMC - PubMed

Grants and funding

This research received no external funding.